These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3796739)

  • 1. [Bronchodilators: theophylline derivatives].
    Neijens HJ
    Ned Tijdschr Geneeskd; 1986 Nov; 130(46):2068-71. PubMed ID: 3796739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of bronchodilators in the therapy of obstructive respiratory diseases].
    Fortschr Med; 1983 Mar; 101(10):435-6. PubMed ID: 6840647
    [No Abstract]   [Full Text] [Related]  

  • 3. [The grade of dyspnea in patients treated with a theophylline derivative (bamifylline) vs controlled-absorption theophylline].
    Giosuè S; Parola D; Cafaggi R; Astengo D; Greco G; D'Onofrio V
    Clin Ter; 1987 Dec; 123(6):457-63. PubMed ID: 2972503
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic action of a new xanthine derivative in respiratory pathology].
    Cesco G; Biondi T; Mazzini R
    Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators.
    Chapman KR; Wanner A
    Am Rev Respir Dis; 1988 Oct; 138(4):1074-5. PubMed ID: 2904777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases].
    Rabe KF; Dent G; Magnussen H
    Pneumologie; 1997 Mar; 51(3):303-16. PubMed ID: 9173421
    [No Abstract]   [Full Text] [Related]  

  • 8. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 9. [A strategy of drug treatment of obstructive respiratory tract diseases].
    Slapke J; Adolph J
    Z Arztl Fortbild (Jena); 1989; 83(17):857-9. PubMed ID: 2686213
    [No Abstract]   [Full Text] [Related]  

  • 10. Theophylline: taking it to a new level.
    Messerschmidt K
    S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341
    [No Abstract]   [Full Text] [Related]  

  • 11. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease.
    Antognozzi G; Buzzo P; Mori M; Ellena S; Triolo A
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):69-72. PubMed ID: 7480962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxic dermatitis induced by bamifylline. 2 cases].
    Carsuzaa F; Schranz J
    Presse Med; 1993 Mar; 22(10):494. PubMed ID: 8511075
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings of the Theophylline Forum. Stockholm, 25 June 1994.
    Clin Exp Allergy; 1996 Mar; 26 Suppl 2():1-59. PubMed ID: 8963869
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
    Macha HN; Aurich R
    Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)].
    Bonaduce D; Ferrara N; Canonico V; Cocozza M; Petretta M; Romano E; Rengo F
    G Ital Cardiol; 1981; 11(10):1467-71. PubMed ID: 7341317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bronchospasmolytic effectiveness of controlled drug combinations].
    Forche G; Zenker G; Harnoncourt K
    Wien Med Wochenschr; 1986 May; 136(9):213-8. PubMed ID: 3739357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
    Dini FL; Cogo R
    Curr Med Res Opin; 2001; 16(4):258-68. PubMed ID: 11268710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is routine monitoring of theophylline blood levels really effective?].
    Atsmon J; Priel IE; Dolev E
    Harefuah; 1995 Nov; 129(9):304-8, 368. PubMed ID: 8549976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theophylline in treatment of bronchial obstructive diseases].
    Rogala B
    Wiad Lek; 1998; 51(3-4):117-21. PubMed ID: 9658984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New developments in the field of bronchospasmolytics].
    Nolte D
    Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.